Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Gemcitabine and Cisplatin Plus AGS-003-BLD in Patients With Muscle-Invasive Bladder Cancer Undergoing Neoadjuvant Cisplatin-Based Chemotherapy

NCT02944357 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02944357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02944357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Gemcitabine and Cisplatin Plus AGS-003-BLD in Patients With Muscle-Invasive Bladder Cancer Undergoing Neoadjuvant Cisplatin-Based Chemotherapy
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2016
Completion date
September 5, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infiltrating bladder urothelial carcinoma, stage ii bladder urothelial carcinoma, stage iii bladder urothelial carcinoma, stage iv bladder urothelial carcinoma